Hyperbaric Oxygen Therapy Devices Market to Expand At A CAGR Of 6.5% through 2025|Key participants IHC Hytech B.V.

The Report Hyperbaric Oxygen Therapy (HBOT) Devices/Equipment Market Analysis By Product (Monoplace, Multiplace, Topical HBOT Devices), By Application (Wound Healing, Infection Treatment, Gas Embolism), And Segment Forecasts, 2018 - 2025

The global hyperbaric oxygen therapy devices market is expected to reach USD 3.91 billion by 2025, according to a new report by Grand View Research, Inc. Growing inclination of healthcare professionals toward oxygen therapy, despite a lack of conclusive evidence is one of the key factors expected to drive the market over the coming few years.

Although the off-label usage of HBOT devices in various applications such as cancer and brain injury is controversial, the adoption rate of this technology is surging at a rapid pace. The high commercial availability of HBOT systems is one of the crucial factors that is anticipated to drive the market over the forecast period. However, few medical professionals are still skeptical about the usage of HBOT devices in unapproved applications, which is expected to impede growth. The technological advancements in this field such as portable HBOT system and growing awareness among healthcare professionals regarding the benefits of integrating ICU systems in multiplace HBOT equipment are some of the key contributors that are accountable for robust growth rate.

According to few publications, nearly 30,000 HBOT treatments are done on a daily basis globally. Other than the surging clinical prevalence and rising adoption of hospital setting HBOT systems, there is a considerable growth in popularity and demand for HBOT systems in home settings owing to its easy usage. Increasing private & public investment to expand geographical presence and surging R&D activities are also some of the factors that are anticipated to boost the demand.

Access Research Report of Hyperbaric Oxygen Therapy Devices Market @ www.grandviewresearch.com/industry-analysis/hyperbaric-oxygen-therapy-market

Further Key Findings From the Report Suggest:

• The global hyperbaric oxygen therapy (HBOT) market size was estimated at USD 2,210.5 million in 2016 and is expected to grow at a CAGR of 6.5% from 2017 to 2025
• Monoplace HBOT Devices segment emerged as the largest product segment in 2016 and is estimated to generate revenue over USD 3,008.8 million by 2025
• Other applications such as acute carbon monoxide poisoning, chemotherapy-induced hemorrhagic cystitis, and cyanide poisoning generated revenue of USD 229.1 million in 2016 and is anticipated to witness fastest growth over the next 8 years
• The Asia Pacific region is anticipated to witness lucrative growth over the next decade owing to various developments in healthcare infrastructure and technological advancements in the medical device industry across major emerging economies. It is expected to grow at a CAGR of 7.1% over the forecast period.
• Some of the key players including Fink Engineering; HAUX-LIFE-SUPPORT; ETC Hyperbaric Chambers (Environmental Tectonics Corporation); Gulf Coast Hyperbarics, Inc.; IHC Hytech B.V. (Royal IHC); HEARMEC; Hyperbaric; Sechrist Industries, Inc.; OxyHeal International; and SOS Group Global Ltd. dominated the global hyperbaric oxygen therapy devices market.

Grand View Research has segmented the global hyperbaric oxygen therapy (HBOT) devices market on the basis of product, application, and region:

HBOT Devices Product Outlook (Revenue, USD Million, 2014 - 2025)

• Monoplace HBOT Devices
• Multiplace HBOT Devices
• Topical HBOT Devices

HBOT Devices Application Outlook (Revenue, USD Million, 2014 - 2025)

• Wound Healing
• Decompression Sickness
• Infection Treatment
• Gas Embolism
• Others

HBOT Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

ePharmacy Market Expected To Expand At A CAGR Of 14.8% From 2018 To 2025

The global ePharmacy market is expected to reach USD 109.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by constant increase in the number of internet users, improved access to web-based & online services, and rapid increase in aging population who find it difficult to visit pharmacies. Convenience, affordability, and ease in availability of medicines are fueling market growth.

Increase in prevalence of chronic conditions and diseases across the globe is resulting in constant growth in demand for various drugs and healthcare products. High cost of treatment is indicating the need to reduce health care cost. Online pharmacies are gaining popularity owing to lucrative offers such as price discounts that result in cost savings. In addition, increase in adoption of e-prescriptions in hospitals and other healthcare facilities is further expected to boost growth.

High unmet needs of emerging economies is one of the key driving factors. Government initiatives, increase in investments, changing regulations, and increasing penetration of internet and broadband in urban as well as rural areas are contributing to the growth of the market. Many new players are entering the market as the healthcare sector is offering huge potential to the online health retailers due to the ever growing demand for healthcare products and services.

However, growth in illegal online pharmacies is restraining the growth. These illegitimate websites may offer counterfeit and unapproved drugs, which make people skeptical about purchasing medicines online.

Access Research Report of ePharmacy Market @ https://www.grandviewresearch.com/industry-analysis/epharmacies-market

Further Key Findings From the Report Suggest:

• North America held majority of the share in 2016 due to increase in online purchases, growing elderly population, and high adoption of IT in healthcare
• The U.S. is the largest market in North America owing to the presence of various key players and a large tech-savvy population
• Asia Pacific is expected to be the fastest growing segment due to the presence of emerging economies like China & India and improving infrastructure
• Some of the key players are The Kroger Co., Walgreen Co.; Wal-Mart Stores, Inc.; CVS Health; Express Scripts Holding Company; Giant Eagle, Inc.; DocMorris (Zur Rose Group); Rowlands Pharmacy; and OptumRx, Inc.

Grand View Research has segmented the ePharmacy market on the basis of region:

e-Pharma Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Soft Tissue Repair Market To Reap Over USD 10.73 Billion In Revenues By End Of 2025

The global soft tissue repair market size is expected to reach USD 10.73 billion by 2025, expanding at a CAGR of 7.3%, according to a new report by Grand View Research, Inc. Growing number of trauma patients and orthopedic surgeries is one of the key factors expected to drive revenue growth in coming few years.

Soft tissue comprises of muscles, ligaments, tendons, fibrous tissue, skin, synovial membranes, nerves and others which protect organs, enable movement and support bones in the body. Injury to the soft tissues can cause severe pain and also may stop movement of the bones, which if left untreated can lead to chronic pain. Over the long-term, injuries hamper everyday life of the patients as it becomes difficult to work, socialize or even move. Most of the injuries are caused because of sprain, trauma of strain on the muscles. Soft tissue repair surgery comprises of procedures wherein devices like grafts, sutures, anchors and other devices are used to remodel, reshape or fix the damaged parts to restore its functionality. With the growing number of related injuries, the products used in repair surgeries are expected to witness exponential demand over the forecast period.

Factors influencing soft tissue repair market growth are growing number of patients suffering from sports related injuries. Sprains, contusions, strains, tendinitis, and bursitis are some common injuries, that are suffered by athletes. Growing awareness about impact of these injuries on athletes’ performance and awareness regarding available treatment options for soft tissue repair are expected to promote revenue growth of the market. Ageing population is another significant factor promoting revenue growth. Old people are more susceptible to fractures and trauma associated injury and often require joint replacement and reconstruction surgeries. According to a United Nations report in 2015, the population of people aged 60 years and above is projected to grow by 56% and is expected to reach 1.4 billion by 2030. This in turn is expected to bolster the patient pool for joint replacement and soft tissue repair surgeries and in turn propel revenue growth of the market over the forecast period.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/soft-tissue-repair-market

Further Key Findings From the Report Suggest:

• The global soft tissue repair market size was estimated at USD 5.73 billion in 2016 and is expected to grow at a CAGR of 7.3% from 2017 to 2025
• Fixation products emerged as the largest product type segment in 2016 and is estimated to generate revenue over USD 6.15 billion by 2025
• Orthopedic surgery segment was estimated at USD 1.47 billion in 2016 and is anticipated to witness fastest growth over the forecast period
• The Asia Pacific region is projected to witness substantial growth over the next decade owing to various developments across major economies in the region. This regional market is expected to grow at a CAGR of 7.7% from 2017 to 2025
• Some of the key players including Stryker Corporation; Arthrex, Inc.; C.R.Bard, Inc., Integra LifeScience Corporation, Smith & Nephew plc. and Depuy Synthes

Grand View Research has segmented the global soft tissue repair market on the basis of product, application and region:

Soft Tissue Repair Product Outlook (Revenue, USD Million, 2014 - 2025)

• Fixation Products
  • Suture
  • Suture Anchors
• Tissue Patch/Match
  • Biological
  • Synthetic

Soft Tissue Repair Application Outlook (Revenue, USD Million, 2014 - 2025)

• Orthopedic Surgery
• Breast Reconstruction
• Hernia Repair
• Skin Repair
• Vaginal Sling Repair
• Cardiovascular Surgery
• Dental Reconstruction
• Others

Soft Tissue Repair Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pruritus Therapeutics Market to Record an Exponential CAGR by 2025

Global pruritus therapeutics market is expected to reach USD 16.38 Billion by 2025, according to a new study by Grand View Research, Inc. Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis and urticaria is expected to drive market growth during the forecast period. Introduction of new products based on scientific mechanistic understanding such as the identification of new T-cell subsets, particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus) is expected to open up new avenues for manufacturers to capitalize on over the forecast period. 

Corticosteroids were the leading product segment in 2013 owing to high efficacy exhibited by this class of drugs in treating pruritic conditions by reducing inflammation and itching. Topical applications of corticosteroids have been found to be extremely effective in the treatment and maintenance therapies pertaining to pruritus.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/pruritus-therapeutics-market

Further key findings from the study suggest:

• Calcineurin inhibitor is identified as the most lucrative segment of the market on account of high usage rate of these drugs in combination therapy for the treatment of pruritus in patients suffering from chronic pruritus and growing market penetration rates. Moreover, the introduction of new products such as Pimecrolimus cream and Tacrolimus ointment is expected to further drive this market.
• Anti-histamines owing to its growing use as a first line treatment and presence of drugs in pipeline with expected commercialization is also expected to grow at a healthy rate during the forecast period.
• North America led the overall market in terms of revenue in 2013 majorly on account of the presence of high prevalence of diseases associated with pruritus, introduction of new products targeting the unmet medical needs and growing patient awareness levels.
• The Asia Pacific pruritus therapeutics market is expected to grow at a CAGR of over 5.0% during the forecast period. Presence of high unmet healthcare needs and increasing prevalence of allergic contact dermatitis and urticaria in this region are some factors attributing to its rapid growth rate.
• Some key participants of the pruritus therapeutics market include Sanofi, Pfizer, Tai Guk Pharmaceutical Company, Actavis, Trevi Therapeutics, Cara Therapeutics, Ocera Therapeutics Inc. and NeRRe Therapeutics.
• Manufacturers adhere to rigorous R&D in an attempt to develop cost effective products and avoid barriers such as product recalls. In addition, this strategy is implemented keeping the unmet needs in consideration. For Instance, Creabilis has a molecule in the pipeline – CT327, which caters to the unmet needs associated with pruritus in patients suffering from psoriasis. 

Grand View Research has segmented the global pruritus therapeutics market on the basis of product, disease type and region:

Global Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)

• Corticosteroids
• Antihistamines
• Local Anesthetics
• Counterirritants
• Immunosuppressant
• Calcineurin Inhibitors
• Others

Global Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)

• Atopic Dermatitis
• Allergic Contact Dermatitis
• Urticaria
• Others

Global Pruritus Therapeutics Regional Outlook (Revenue, USD Million, 2012 - 2025)

• North America
  • US.
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • Rest of Asia Pacific
• RoW 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Human Growth Hormone Market to Expand At A CAGR Of 8.2% from 2020 to 2027

The global human growth hormone market size is expected to reach a value of USD 8.5 billion by 2027, registering a CAGR of 8.2% over the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel therapies, increasing R&D activities, and rising awareness for the diagnosis and treatment of growth hormone (GH) disorders are expected to drive the market over the forecast period.

Key players operating in the market are involved in extensive R&D activities for the development of novel GH therapies to strengthen their position in the market. For instance, in October 2019, VISEN Pharmaceuticals, a joint venture of Denmark-based Ascendis Pharma A/S, received approval from China National Drug Administration (NMPA) for its new drug (IND) application to start Phase III clinical study of TransCon hGH. Furthermore, two South Korean companies, Genexine Inc. and Handok Inc., are conducting a Phase II clinical trial study on GX-H9, a recombinant human GH for the treatment of adult and pediatric GH deficiency.

Furthermore, increase in the number of regulatory approvals and launch of novel hGH therapies are expected to fuel the market over the forecast period. For instance, in January 2018, Ferring Pharmaceuticals Inc., a Switzerland-based pharmaceutical company, received United States Food and Drug Administration (USFDA) approval for its new recombinant hGH, Zomacton (somatropin) indicated for the treatment of adult patients with GH deficiency.

Various government and private organizations have been undertaking initiatives and programs to spread awareness about GH deficiency and facilitate timely diagnosis and treatment. Nonprofit organizations such as Human Growth Foundation are engaged in providing research support and spreading awareness about GH deficiency and its treatment. Such initiatives are expected to drive the demand for hGH treatment therapies.

Access Research Report of Human Growth Hormone Market @ https://www.grandviewresearch.com/industry-analysis/human-growth-hormone-drugs-market

Further key findings from the study suggest:

• GH deficiency was the largest application segment in 2019 owing to increase in regulatory approvals and launch of novel therapies
• Rising awareness about GH deficiency, coupled with increasing hospital visits for its treatment, is expected to drive the hospital distribution channel segment
• North America dominated the human growth hormone market with the largest share in 2019. This is attributed to favorable reimbursement scenario, high awareness, and the presence of major players in the region
• Asia Pacific is projected to witness a lucrative CAGR over the forecast period owing to increasing penetration of key players with their new growth hormone therapies
• The key players include Novo Nordisk A/S; Pfizer Inc.; Eli Lilly and Company; Sandoz International GmbH (Novartis AG); Merck KGaA; Genentech, Inc. (Roche); Ferring Pharmaceuticals; Teva Pharmaceutical Industries, Ltd; and Ipsen.

Grand View Research has segmented the global human growth hormone market on the basis of application, distribution channel, and region:

Human Growth Hormone (hGH) Application Outlook (Revenue, USD Million, 2016 - 2027)

• Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Small for Gestational Age
• Other

Human Growth Hormone (hGH) Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Specialty Pharmacy

Human Growth Hormone (hGH) Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ophthalmic Devices Market is Expected to Grow at the Fastest CAGR at over 6.0% by 2024| Key participants Johnson & Johnson, Essilor International S.A

The global ophthalmic devices market is expected to reach USD 55.5 billion by 2024, according to a new report by Grand View Research, Inc. The rising geriatric population base is presumed to propel the need for ophthalmic devices as this age group is more prone towards the development of chronic eye disorders. The rising prevalence of eye disorders such as macular degeneration, cataract, diabetic retinopathy and glaucoma is also boosting the growth of ophthalmic devices.

Approximately 10% of the people suffering from eye disorders will experience loss of vision in spite of the proper treatment as per the statistics of the WHO, driving the clinical urgency to incorporate highly advanced ophthalmic devices. Additionally, the rising demand for minimally invasive and complication-free operative surgeries is expected to upsurge the demand for ophthalmic devices.

The ophthalmic devices market growth can also be attributed to technological advancements such as the development of intraocular lenses, mydriatic fundus cameras, and OCT devices. Furthermore, the increasing involvement of market players in expanding treatment solutions through strategic alliances is expected to present this market with a potential growth platform. For instance, in May 2016, Bausch & Lomb through its enterprise partnership with Apple and IBM will develop a cataract surgery app that would integrate patient data, calculation data, and records thereby helping cataract surgeons’ work efficiently. The app will be enabled with IBM’s cognitive computing capabilities to reduce surgical errors.

Access Research Report of Ophthalmic Devices Market @ https://www.grandviewresearch.com/industry-analysis/ophthalmic-devices-market

Further key findings from the study suggest:

• The vision care segment dominated the product segment of the overall ophthalmic devices market in terms of revenue share at over 78.0%in 2015,owing to its adoption in vision correction procedures and the rising number of initiatives to promote the awareness pertaining to vision care
• For instance, in April 2016, Alcon announced its support to the “Think About Your Eyes”, which is a public awareness program. Alcon committed USD 4 million to support this initiative to promote the awareness pertaining to vision care
• The diagnostic& monitoring devices segment is expected to grow at the fastest CAGR at over 7.0% in 2015. This can be attributed to the fact that diagnosis is an indispensable process in the treatment of eye disorders and is responsible for contributing towards the diagnostics & monitoring segment’s growth
• In 2015, North America dominated the overall ophthalmic devices market at over 36.0%owing to the increasing utilization of ophthalmic devices in hospitals and private clinics. Moreover, subsequent changes in demographic trends, such as a rise in the geriatric population & unhealthy lifestyles, are presumed to drive the market in this region. Moreover, high R&D investments in the development of new products are expected to impel the market growth in North America
• Asia Pacific is anticipated to be growing at the fastest CAGR of around 7.0% over the forecast period due to the presence of untapped opportunities in the emerging economies in China and India. Moreover, the increasing government initiatives towards healthcare infrastructure; for instance, in China, healthcare reforms through an initiative called New Health Care Reform Plan implemented by the Chinese State Council and the Communist Party of China (CPC) Central Committee is expected to drive growth of the Chinese regional market.
• Some key players in this market are involved in adopting collaborative strategies and indulge in frequent product approvals to facilitate business and geographical expansions. For instance, in February 2016, Alcon acquired Transcend Medical, Inc., in a probe to expand its business in the treatment of glaucoma. This acquisition added Minimally Invasive Glaucoma Surgical (MIGS) devices to Alcon’s product portfolio.

Grand View Research has segmented the ophthalmic devices market on the basis of product and region:

Global ophthalmic devices product outlook (Revenue, USD Million, 2013 - 2024)

• Diagnostics & Monitoring Devices
• Surgical Instruments
• Vision Care Products

Ophthalmic devices regional outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Personal Mobility Devices Market Poised to Garner Maximum Revenues During 2020 – 2027

The global personal mobility devices market size is expected to reach USD 17.9 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.5% over the forecast period. Growing R&D investments for new product development and government initiatives aimed at strengthening reimbursement frameworks are some of the key factors propelling market growth.

Surge in geriatric population and prevalence of target diseases such as arthritis, Parkinson’s, and Alzheimer’s among the global population are some key factors expected to drive the personal mobility devices market market over the forecast period. According to WHO in 2019, the number of people aged 60 and above is likely to grow by 56.0% from 962 million in 2017 to 1.4 billion in 2030.

Rising number of surgical procedures due to rising prevalence of neurological and cardiovascular disorders and increasing number of accidents and trauma cases are expected to drive the market for personal mobility devices over the forecast period. According to WHO the number of surgeries grew by about 40.0% from 2004 to 2012.

Europe was the most mature market for personal mobility devices in 2019. It generated the maximum revenue that year, accounting for 33.0% of the global market. Sophisticated healthcare infrastructure and growing healthcare expenditure are some of the factors contributing to its dominant share. Asia Pacific is expected to grow at a lucrative pace during the forecast period. This region is expected to witness a rapid gain in demand for personal mobility devices over the coming years owing to growing geriatric population, increasing disposable income and greater spending on healthcare, and rising awareness levels about the availability of various kinds of personal mobility devices.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/personal-mobility-devices-market

Further key findings from the report suggest:

• By product, wheelchair was the largest segment in 2019 owing to increase in demand for powered wheelchairs, especially in developed countries such as U.S. and Germany
• Premium rollators are identified as the most lucrative segment in this market owing to its ability to handle heavy weight, enhanced height, and handle adjustment mechanism
• Europe dominated the market in 2019 with a 33.0% share due to growing geriatric population and increase in healthcare expenditure in the region
• Asia Pacific is expected to grow at a rapid pace over the forecast period owing to growing geriatric population, increasing disposable income, and rising awareness levels
• Some of the players operating in the market are Drive DeVilbiss Healthcare; GF HEALTH PRODUCTS, INC.; Invacare Corporation; Carex Health Brands, Inc.; Kaye Products, Inc.; Briggs Healthcare; Medline Industries, Inc.; NOVA Medical Products; Performance Health; and Rollz International
• Development of advanced personal mobility devices via extensive R&D investments and entering into strategic alliances with buyers are some key sustainability strategies adopted by these market players.

Grand View Research has segmented the global personal mobility devices market based on product and region:

Personal Mobility Devices Product Outlook (Revenue, USD Million, 2016 - 2027)

• Wheelchairs
  • Manual
  • Power
• Scooters
• Walking Aids
  • Rollators
    • Low cost
    • Premium
  • Other Walking aids (canes, crutches, walkers)

Personal Mobility Devices Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Switzerland
  • Russia
  • Sweden
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
  • Malaysia
  • Indonesia
  • Singapore
  • Philippines
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antidiabetics Market Booming Trends and Forecast Assessment for the Period 2020

Global antidiabetics market is expected to reach USD 84.13 billion by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by triggering incidence rates of target diseases. Future commercialization of products currently in the pipeline and the presence of large untapped opportunities in the emerging Asia Pacific and Latin American markets is expected to fuel future market growth.

Insulin was the most revenue generating segment and its market was valued at over USD 20.0 billion in 2013. Insulin is also one of the most lucrative segments of this market. Introduction of new products exhibiting higher efficacy coupled with the presence of favorable government initiatives are some factors attributing to its market attractiveness.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/antidiabetics-market

Further key findings from the study suggest:

• Long acting insulin was the leading product segment in 2013 and is expected to grow at the CAGR of over 15.0% during the forecast period. The introduction of advanced products, high prices associated with these products and the phasing out of human insulin are some key factors attributing for its large share.
• Rapid uptake of newly approved DPP-4 inhibitors such as Januvia, Nesina and Onglyza on account of their once daily dosage regimens and safety profiles catalyzed the growth of this market.
• North America was the most matured antidiabetics market in 2013 accounting for over 43.0% of the market High market penetration of insulin and other antidiabetics and the presence of sophisticated reimbursement framework are expected to drive regional market growth.
• Asia Pacific is expected to present manufacturers with lucrative future growth opportunities. Large presence of unmet patient needs and rapidly improving healthcare infrastructure are some factors expected to drive market growth in the region. The market is also expected to be driven by the introduction of cheaper products made available by local manufacturers.
• Some key market players of antidiabetics include Sanofi Aventis, Takeda Pharmaceuticals, Eli Lilly, Oramed Pharmaceuticals Inc., Merck & Co. Inc., Novo Nordisk, Bristol-Myers Squibb, Halozyme Therapeutics and Pfizer.
• The market is oligopolistic in nature with few players accounting for over 70% of the market. Extensive R&D investments aimed at new product development and entering new markets via government contracts are the key sustainability strategies adopted by these organizations.

Grand View Research has segmented the global antidiabetics market on the basis of product and region:

Global Insulin Product Outlook (Revenue, USD Million, 2012 - 2020)

• Rapid acting
• Long acting
• Premixed
• Premixed analog
• Short acting
• Intermediate acting

Global Antidiabetics Product Outlook (Revenue, USD Million, 2012 - 2020)

• Alpha-glucosidase inhibitors
• Biguanides
• Sulphonylureas
• GLP-1 agonist
• Meglitinides
• DPP-4 inhibitors
• SGLT - 2
• Thiazolodinediones

Antidiabetics Regional Outlook (Revenue, USD Million, 2012 - 2020)

• North America
• Europe
• Asia Pacific
• RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Electronics Market Size, Share, Trends, Analysis And Growth Forecast To 2024

The global medical electronics market size is expected to reach USD 219.0 billion by 2024, according to a new report by Grand View Research. Technological advancements have boosted the applications of electronics in the fields of diagnostics, therapeutics, and wellness. Increasing geriatric population coupled with sedentary lifestyle contributes to chronic cardiovascular, gastrointestinal, and respiratory disorders.

Diagnostic applications of medical electronics are fueled due to growing awareness about healthcare amongst people. Population in developed countries opts for early diagnosis for effective treatment and cure. Increasing adoption of newer technology in diagnostics is expected to upsurge the market in future. 

Aging population creates need for critical care of long duration, thus increasing the demand for life-supporting devices, such as ventilators and dialysis devices. Growing number of accidents and permanent injuries also contribute to this upsurge. Improving healthcare facilities eases the procedures of reimbursements and related medical procedures even in developing countries.

Industry players are focused on the commercialization of new technologies and integrated systems. In August 2016, Siemens launched a new product, Sysmex CS-2500. It is a coagulation analyzer and has applications in diagnostics. 

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-electronics-market

Further Key Findings from the Study Suggest:

• Rising prevalence of chronic diseases, such as neurodegenerative and cardiac diseases, creates a need for continuous patient monitoring. Constant development of technologies such as real-time audio/video feed, wireless communications, and remote patient monitoring proves to be a boon for chronic patients, especially those who prefer to receive treatment at home. All these factors are expected to act as a catalyst for the market growth over the forecast period.
• The largest application of medical electronics is in the field of diagnostics, especially imaging. Increasing importance of early disease diagnosis is promoting the growth of this segment. Magnetic resonance imaging is the most common method used, owing to the growing neurological and musculoskeletal disorders and the development of superconducting magnets.
• Ultrasound is projected to be the fastest-growing segment of medical imaging, owing to its applications in point-of-care and musculoskeletal diseases. Growing birth rate also contributes to the usage of ultrasound. Rising awareness coupled with government recommendations about periodic screening for cancer also contributes to this growth.
• Considering home healthcare medical electronics, device such as glucometer is used by diabetic patients owing to the ease of use of the device, and cost-effectiveness.
• The emphasis on preventive measure and early diagnosis rather than on treatment is driving the industry players to invest in remote, wireless, and minimally invasive equipment. This is predicted to set the trend of telehealth, self-monitoring, and home healthcare. In February 2016, Medtronic launched its first remote monitoring pacemaker in Canada. The data collected and interpreted is transmitted securely to the physician to make efficient treatment decisions.
• North America dominated the medical electronics market owing to the presence of well-structured healthcare and reimbursement systems. High prevalence of chronic lifestyle diseases, growing awareness about the importance of early diagnosis, and acceptance of new technology contributed to the market growth in this region.
• Asia pacific is expected to emerge as the fastest growing region during the forecast period. The huge patient pool in Asia Pacific proves to be an attractive opportunity for companies to market their products in this region. Improving healthcare systems, high incidence rate of diseases and accidents, and stabilizing economies aid the market growth.
• Some key participants include EDDA technology, Inc., Philips healthcare, FUJIFILM Medical Systems, Hitachi High Technologies Corporation, Toshiba Medical Systems Corporation, McKesson Corporation, Vucomp, Hologic Inc., Siemens Healthcare and iCAD, Inc.
• The current trend of investing in development of new technologies is expected to benefit patients as well as practitioners. For instance, in March 2016, Maxim Integrated launched its new heart rate monitor integrated with pulse oximeter. This device helps in continuous monitoring and efficient treatment of cardiovascular patients.

Grand View Research has segmented the global medical electronics market by application:

Medical Electronics Application Outlook (Market revenue in USD Million, 2013 - 2024)

• Imaging
  • MRI Equipment
  • Computed Tomography (CT)
  • Nuclear imaging equipment
  • X-ray Devices
  • Ultrasound Systems
• Therapeutics
  • Cardiac Rhythm Management (CRM)
  • Dialysis
  • Continuous Positive Airway Pressure (CPAP)
  • Neuromodulation
  • Others
• Patient monitoring
• Home Healthcare/Handheld products

Medical Electronics Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Enterprise Wearable Market Technological Advancement and Regional Outlook During 2018-2025

The global enterprise wearable market is expected to reach USD 22.3 billion by 2025, according to a new study conducted by Grand View Research, Inc. The high demand for enterprise wearable devices in the Asia Pacific region is anticipated to drive the industry growth over the next decade. The aging population and rising chronic diseases, such as coronary heart diseases and diabetes, in countries such as China, India, and Japan would drive the demand for wearable technology in the region.

Industry players are investing a significantly in research & development activities for product innovation, thus catering to the specific needs of the enterprise industry. They are using strategies such as acquisition, partnerships, and collaborations to maintain market competencies.

The rising enterprise applications of Virtual Reality (VR) and Augmented Reality (AR) in the following years is expected to fuel the demand for wearable devices, such as smart eye wear and head mounted devices.  This growth in demand may be attributed to advancements in the VR and AR technologies, which would help increase their connectivity and enterprises’ interaction with employees and consumers.

The increasing awareness regarding health and wellness, rising aging population, and chronic diseases such as heart attack and diabetes, globally, are favorable factors expected to support the demand for wearable devices over the forecast period.

The rising demand for IoT technology, owing to its wide application in various sectors such as healthcare, manufacturing, retail, and others, is foreseen to drive the growth of the enterprise wearable market. The IoT technology, along with wearable devices, would help organizations in the development and deployment of the future generation value-added services by utilizing user-centric data.

Access Research Report of Enterprise Wearable Market@ http://www.grandviewresearch.com/industry-analysis/the-global-enterprise-wearables-market

Further key findings from the study suggest:

• The IoT technology segment is expected to surpass the Bluetooth segment and dominate the market after 2022 as well. This growth may be attributed to the expected rise of widespread real-time applications of IoT technology in different industries globally over the next decade.
• The demand for head wear devices is expected to gain momentum over the forecast period owing to their prospective applications in highly developing technologies such as VR and AR
• The Asia Pacific region is predicted to emerge as the fastest growing market owing to a significant rise in the number of adopters of medical wearable devices for monitoring bodily conditions, such as glucose level, heart condition, temperature, sleep, and others, in countries such as China and India
• Prominent vendors operating in the market include Fitbit Inc., Apple Inc., Alphabet Inc., Xiaomi Inc., Samsung Electronics Co. Ltd., Eurotech SpA, Adidas AG, and Seiko Epson Corporation
• The increased focus on research and development activities for new product developments and upgrades of existing products to meet industry demands are the key trends adopted by industry player

Grand View Research has segmented the global enterprise wearable market on the basis of technology, product, application, and region:

Technology Outlook (Revenue, USD Million; 2014 - 2025)

• IoT
• Bluetooth
• Bluetooth Low Energy (BLE)

Product Outlook (Revenue, USD Million; 2014 - 2025)

• Wrist-wear
• Foot wear
• Eye wear
• Arm wear
• Head wear

Application Outlook (Revenue, USD Million; 2014 - 2025)

• Infotainment
• Healthcare
• IT & telecom
• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

UV Tapes Market is Expected To Reach USD 677.2 Million by 2025| Key participants Pantech Tape Co. Ltd., Ultron Systems, Inc.

Global UV tapes market is expected to reach USD 677.2 million by 2025, according to a new report by Grand View Research, Inc. Growing electronics and semiconductor industries are expected to play key roles in the market growth over the forecast period. Polyolefin was one of the primary raw material used in manufacturing of UV tapes. These tapes were most widely used in 2015 on account of high performance characteristics under extreme heat and pressure conditions.

Growing demand for miniaturized semiconductor and electronic components have driven the market for ICs and micro-chips, further boosting the UV tapes industry. These tapes are used for applications such as back grinding and wafer dicing, in the semiconductor industry.

Access Research Report of UV Tapes Market@ www.grandviewresearch.com/industry-analysis/uv-tapes-market

Further key findings from the report suggest:

• Wafer dicing was the most dominant application in 2015 owing to rapid electronics industry growth, as it involves sawing or cutting of wafer into a precise size and shape for use in electronic devices
• The back grinding application accounted for over 40% of the industry by value in 2015 due to growing demand for compact-sized and powerful electronic devices such as smartphones and tablets
• The polyolefin (PO) UV tapes market was valued at over USD 150 million in 2015 on account of their superior performance as compared to other alternatives such as PVC and PO UV tapes
• PVC UV tapes held a share of over 20% by value in 2015, as they are considered eco-friendly and can be easily recycled, thus increasing their popularity over the past few years
• Asia Pacific is projected to witness the highest CAGR of over 10% from 2016 to 2025 courtesy growing demand from its booming electronics and semiconductor industries
• Electronic powerhouses such as China, Taiwan, South Korea and Japan accounted for the majority of the market in the Asia Pacific region in 2015 due to the presence of major electronics players such as Toshiba, Pioneer, Samsung, Hitachi and Sharp
• Central & South America is projected to witness the second-highest CAGR of over 9% from 2016 to 2025 on account of growing demand from emerging countries in this region such as Brazil, Colombia, and Argentina
• The industry is consolidated with a limited number of manufacturers and distributors across the world with Furukawa Electric Co. Ltd., Mitsui Chemicals, Lintec Corporation, and Nitto Denko Corporation being the key players in 2015
• These players resorted to both, organic as well as inorganic growth strategies, in order to enter new regions and increase their respective market shares

Grand View Research has segmented the global UV Tapes market on the basis of product, application and region:

Product Outlook (Volume, Million Square Meters: Revenue, USD Million, 2014 - 2025)

• Polyolefin (PO) UV Tapes
• Polyvinyl Chloride (PVC) UV Tapes
• Polyethylene Terephthalate (PET) UV Tapes
• Other UV Tapes

Application Outlook (Volume, Million Square Meters: Revenue, USD Million, 2014 - 2025)

• Wafer Dicing
• Back Grinding
• Others

Regional Outlook (Volume, Million Square Meters: Revenue, USD Million, 2014 - 2025)

• North America
  • US.
• Europe
  • Germany
  • France
• Asia Pacific
  • China
  • South Korea
• Latin America
  • Brazil
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Agricultural Robots Market is Anticipated to Register 24.7% CAGR through 2025| Key Industry Participants CNH Industrial (UK)

The Report Agricultural Robots Market Analysis By Product (UAV, Driverless Tractor, Milking Robots, Materials Management), By Application (Field Farming, Dairy, Animal, Soil & Crop Management), & Segment Forecasts, 2018 – 2025

The global agricultural robot market is anticipated to reach USD 8.82 billion by 2025, according to a new report by Grand View Research, Inc. The agriculture industry is changing dramatically, across the globe. The growing technological advancements and innovations in robotics have increased the sales of the agricultural robots.

Indoor farming refers to crop cultivation using high-pressure sodium lamps or LEDs and growth in aeroponic and hydroponic systems. Additionally, indoor farming provides protection and optimal growing conditions. The use of this technology by small commercial growers for producing crops is expected to increase their capacity and economic viability.

The future of the indoor farming industry is technology and data driven. The climate control technology is enabling high yields. A farm management system helps growers in reducing the time spent on analyzing and collecting crop yield data. The growing adoption of indoor farming is likely to spur the agriculture robot market.

Farm employment includes exposure to pesticides, long working hours, poor sanitary conditions, and other health risks. Most of the agricultural work is physical in nature, which increases the risks of accidents by fatigue, difficult terrain, poorly designed tools, and extreme weather conditions. In addition to physically demanding labor, heat & sun exposure and dangerous machinery increase the risks of farming.

Based on working methods, the working conditions in commercial plantations vary from traditional intensive methods to highly mechanized extensive methods. However, only some of the agricultural workers are covered by employment injury benefits, national legislation, and insurance schemes.

Farming causes several respiratory hazards in farmworkers. Organic dust toxic syndrome (ODTS), caused by grain and silage dust, is a common respiratory illness prevailing among the farmers. Agricultural noise and chemical hazards are the other common health hazards of farming. Prolonged exposure to excessive noise produced by choppers, tractors, chainsaws, and grain dryers can cause permanent hearing loss.

However, lack of awareness and high initial capital investments are anticipated to restrain the market growth over the forecast period. The robots used for agricultural purposes require additional application-specific advanced processing equipment, resulting in increased capital investment.

Access Research Report of Agricultural Robots Market @ www.grandviewresearch.com/industry-analysis/agricultural-robots-market

Further key findings from the report suggest:

• Increasing privatization of agricultural resources and services are expected to drive the market demand
• Milking robots product segment is anticipated to dominate the market in terms of revenue over the projected period
• The growing penetration of vertical farming is likely to spur the materials management product segment
• The ability of drones to hover low over fields along with sensing devices has benefitted the farmers by reducing their dependability on climate
• The Asia Pacific region is witnessing highest penetration growth in the agricultural robot market and possesses greater growth opportunities for companies planning to invest in long haul
• The Chinese agricultural processes have been modernized by the introduction of the crop-dusting drones
• The key players of the agricultural robot market include CNH Industrial (UK), CLAAS (Germany), GEA Group (Germany), and Harvest Automation, Inc. (U.S.)

Grand View Research has segmented the agricultural robot market based on product, application, and region:

Agricultural Robot Product Outlook (Revenue, USD Million, 2014 - 2025)

• UAV
• Driverless tractor
• Milking robots
• Materials management

Agricultural Robot Application Outlook (Revenue, USD Million, 2014 -2025)

• Field farming
• Dairy management
• Animal management
• Soil management
• Crop management

Agricultural Robot Regional Outlook (Revenue, USD Million, 2014 -2025)

• North America
• Europe
• Asia Pacific
• South America
• The Middle East and Africa (MEA)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surge Protection Devices Market Expected To Reach $3.39 Billion by 2025

The global surge protection devices market is expected to reach USD 3.39 billion by 2025, according to a new study by Grand View Research, Inc. The high costs incurred due to electrical equipment downtime are expected to surge the demand for these devices over the forecast period.

The need for protection against lightning and voltage fluctuations has triggered the implementation of SPDs. These devices are available in various types, which are used in an electrical distribution system depending on location requirements. Surge protection devices also ensure proper functioning of electrical equipment during surges caused lightning strikes. Thus, implementation of SPDs is of prime importance for any business or residential and commercial buildings.

The Asia Pacific region is one of the key regions for outsourcing services, owing to favorable government policies. This has led to a significant growth in the number of data centers across the region. As these data centers store information of high importance to the user, any failure in their functioning, due to downtime caused by an electrical surge, would lead to heavy losses. Moreover, increasing renewable energy generation projects across rural regions are further expected to bolster the use of SPDs.   

The rise in disposable income has enabled the adoption of expensive consumer electronic. As these electronic products are subject to regular internal surges, it is essential to safeguard them. Furthermore, in developed regions, the well-established information technology industry is encouraging the use of surge protection devices on a large-scale for protecting electronic hardware such as data servers, desktops, and electrical supply equipment.

Access Research Report of Surge Protection Devices Market @ http://www.grandviewresearch.com/industry-analysis/surge-protection-devices-market

Further key findings from the study suggest:

• The type 2 SPD segment was valued at USD 610.1 million in 2016
• The growing number of hospitals in developing economies, such as India and China, along with widespread healthcare network in developed countries, is anticipated to foster market growth
• Increased electrification of rail networks, coupled with the growing popularity of electric vehicles and their required infrastructure, is predicted to boost the growth prospects of SPDs in the near future
• The North American region is expected to significantly contribute to the industry growth and represented the largest market size with USD 778.3 million in 2016, owing to the widespread awareness of the benefits of SPDs
• The key industry participants include ABB Ltd, Advanced Protection Technologies, Inc., G Power and Industrial Solutions Limited, Eaton Corporation PLC, Emerson Electrical Co., General Electric, Legrand S.A., Schneider Electric, Siemens AG, and Tripp Lite

Grand View Research has segmented the surge protection devices market based on product types, power ratings, applications, and regions:

Surge Protection Devices Product Type Outlook (Revenue, USD Million; 2014 - 2025)

• Type 1
• Type 2
• Type 3
• Type 4

Surge Protection Devices Power Rating Outlook (Revenue, USD Million; 2014 - 2025)

• 0-50 kA
• 1-100 kA
• 1-200 kA
• 1 kA and Above

Surge Protection Devices Application Outlook (Revenue, USD Million; 2014 - 2025)

• Commercial
• Data center
• Industrial
• Medical
• Residential
• Telecom
• Transportation
• Other End-Uses

Surge Protection Devices Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• South America
  • Brazil
• Middle East & Africa (MEA)

 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cochlear Implant Market to Incur Meteoric Growth During the Forecast Period

The global cochlear implant market size is expected to reach USD 3.4 billion by 2026, based on a new report by Grand View Research, Inc. is estimated to grow at a CAGR of around 10.5% over the forecast period. The cochlear implants market is anticipated to witness significant growth during the forecast period, which can be attributed to a favorable reimbursement scenario, rising awareness about hearing aids, and increasing adoption of implants.

Furthermore, technological advancements in cochlear implants to make the device more efficient and user-friendly can boost the demand, which is expected to propel the industry during the forecast period. For instance, in September 2016, Cochlear Ltd. launched the world’s thinnest full-length perimodiolar electrode for their cochlear implant. The thin structure of the implant electrode helps to protect the delicate structures of the inner ear.

By type of fitting, the market is segmented into unilateral and bilateral implantation. In 2018, unilateral implantation segment dominated the industry due to its availability at a low cost as compared to bilateral implantation and significant ability to localize the sound. However, bilateral implantation is anticipated to witness fastest growth during the forecast period. This can be attributed to its cost-efficiency when implanted in children, good reimbursement, and ability to improve the performance after implantation. 

Access Research Report of Cochlear Implant Market @
https://www.grandviewresearch.com/industry-analysis/cochlear-implants-industry

Further Key Findings from the Study Suggest:

• Unilateral implantation dominated the industry in 2018.This can be attributed to its low cost as compared to bilateral implantation and high demand from adults due to its cost-effectiveness.
• Bilateral implantation is the most lucrative segment of the industry. Increasing demand, ability to recognize the speech in noise, and good reimbursement are the key factors expected to drive the market during the forecast period.
• By end use, the adults segment dominated the market in 2018 and is expected to maintain its dominance during the forecast period, due to the presence of a large patient base and growing geriatric population.
• Pediatrics segment is expected to grow at the fastest rate during the forecast period. Increasing implantation at an early age, implementation of several programs & government support to provide cochlear implant to children as early as possible, and good reimbursement are the key factors expected to propel the cochlear implants market.
• Geographically, Europe dominated the industry in 2018 and is expected to maintain its position during the forecast period. This is primarily due to the conducive health infrastructure of the European Union, which allows implantation at an early age.
• Asia Pacific is anticipated to observe the fastest growth over the coming years. This can be attributed to growing awareness in the region and local presence of market players.
• Increasing awareness and growing disposable income in the Middle East region is also expected to boost the market in the region. For instance, in December 2016, Dubai based Prime hospital launched new facility to perform cochlear implant surgery.
• Several players operate in the industry. However, majority of the share belonged to the top two to three players who dominated in the industry in 2018.
• Some of the key players are Cochlear Ltd., MED-EL, Sonova, Gaes Group, William Demant Holding A/S, and Nurotron Biotechnology Co. Ltd. Development of innovative products by focusing on R&D is a key strategy has been adopted by dominant players in the market. In June 2019, Cochlear Limited received the approval from the U.S. FDA for its Cochlear Nucleus Profile Plus Series Cochlear Implant. The implant is designed for safe access to MRI scans.

Grand View Research has segmented the cochlear implants market by type of fitting, by end use, and region:

Cochlear Implants Type of Fitting Outlook (Market Revenue in USD Million, 2015 - 2026)

• Unilateral Implantation
• Bilateral Implantation

Cochlear Implants End Use Outlook (Market Revenue in USD Million, 2015 - 2026)

• Adults
• Pediatrics

Cochlear Implants Regional Outlook (Market Revenue in USD Million, 2015 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Autoimmune Disease Diagnostics Market Share, Growth Analysis And Industry Size Forecasts To 2025

The Report Autoimmune Disease Diagnostics Market Size & Forecast By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics Disease Diagnostics), By Region, And Trend Analysis From 2018 To 2025

The global autoimmune disease diagnostics market is expected to reach a value of USD 5.0 billion by 2025, based on a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases.

Moreover, presence of favorable government initiatives aimed at curbing incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.

Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results.

Access Research Report of Autoimmune Disease Diagnostics Market @ www.grandviewresearch.com/industry-analysis/autoimmune-disease-diagnostics-industry

Further key findings from the study suggest:

• Localized autoimmune disease diagnostics was the largest segment in 2015 owing to high usage for type 1 diabetes and idiopathic thrombocytopenic purpura
• Type 1 diabetes is estimated to grow at a significant growth rate of over 4.0% in localized disease type segment
• Systemic disease diagnostics is anticipated to witness lucrative CAGR of around 5.0% over the forecast period due to increasing R&D for the development of novel diagnostic biomarkers for the treatment of rheumatoid arthritis and systemic lupus erythematosus
• Rheumatoid arthritis is one of the most recurring autoimmune disorders further demanding high amount of rapid diagnostics for exploring better alternative treatments
• North America was the largest regional market in 2015. High market penetration rate of technologically advanced products and increased lab automation rate are some of the factors contributing to its large share
• Asia Pacific region is anticipated to grow at the fastest CAGR of above 4.0% over the forecast period owing to increasing focus on type 1 diabetes diagnosis
• Some of the key players of this market include F. Hoffmann-La Roche Ltd; Siemens Healthineers; Abbott Laboratories; Beckman Coulter, Inc.; SQI Diagnostics; Quest Diagnostics; EUROIMMUN AG; AESKU. Diagnostics; Inova Diagnostics, Inc.; Crescendo Bioscience, Inc.; bioMerieux SA; Bio-Rad Laboratories, Inc.; and Hemagen Diagnostics, Inc.

Grand View Research has segmented the autoimmune disease diagnostics market by type and region:

Autoimmune Disease Diagnostics Type Outlook (Revenue, USD Million, 2014 - 2025)

• Systemic autoimmune disease diagnostics
  • Rheumatoid arthritis
  • Ankylosing spondylitis
  • Systemic lupus erythematosus (SLE)
  • Others
• Localized autoimmune disease diagnostics
  • Multiple sclerosis
  • Type 1 diabetes
  • Hashimoto's Thyroiditis
  • Idiopathic thrombocytopenic purpura
  • Others

Autoimmune Disease Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.